Herein, we present the rare case of a patient with cutaneous metastasis of giant cell-rich osteosarcoma, which closely resembled a giant cell tumor. Owing to the different prognoses and treatment strategies for these tumors, it is important to ensure that the correct differential diag- nosis is made.
A 43-year-old man presented with a 6-month history of nodules on his scalp. He had been diagnosed with giant cell-rich osteosarcoma in his right femur along with metastases to multiple organs, including the lungs and the mandible, 1 year ago. The metastatic lung nodules had increased in size despite 6 months of chemotherapy with ifosfamide, adriamycin, and high-dose methotrexate. Subsequently, oncologists changed the regimen to gemcitabine and docetaxel, but the tumor still progressed. Therefore, the regimen was changed once again, and he was admitted to receive a second cycle of cyclophosphamide and etoposide as a third-line regimen. Upon physical examination, several firm skin-colored to erythematous nodules were palpated on his scalp, each measuring approximately 5∼12 mm (Fig. 1) . Histopathological findings showed many uniformly distributed, multinucleated giant cells containing pleomorphic nuclei. Mononuclear tumor cells had hyperchromatic nuclei with a variety of morphologies, such as round, oval, polygonal, and spindle-shaped (Fig. 2) . Although atypical mitoses or dominant osteoid formations were hardly observed, these histological findings were consistent with those of giant cell-rich osteosarcoma, which was previously confirmed by right femur biopsy (Fig. 2) . Three months later, he died of sepsis following bone marrow failure caused by the continued chemotherapy. Several studies have reported that giant cell-rich osteosarcomas are sometimes misdiagnosed as giant cell tumors because of their similar clinicopathological features 2-4 .
However, these tumors have extremely different clinical courses and prognoses. Giant cell tumors are usually benign with a metastatic rate of ＜2%, while the clinical course of osteosarcoma is extremely aggressive, with rapid hematogenous systemic dissemination and a tumor-related mortality of 75% within 5 years of diagnosis 1, 5 .
For these reasons, Huang et al. 3 suggested the use of some key factors to distinguish these two tumors, including osteoid formation, nuclear pleomorphism, and atypical mitotic figures 3 . However, osteoid formation cannot be found in small biopsy samples or samples from early lesions 4 . Tumor cell pleomorphism is not obvious in some cases 2 . Unless malignant osteoid formation is found, as in this case, it is difficult to confirm an osteosarcoma diagnosis without knowing a patient's cancer history. Unfortunately, not all cases present with features as informative as those in the case reported here. Among 29 cases of giant cell-rich osteosarcoma, only 1 case of cutaneous metastasis had been reported in English literature [2] [3] [4] . With the histological similarity to giant cell tumors, this case emphasizes the value of careful examination of tumor cell pleomorphism and pathological mitoses when patients present with giant cell-rich tumors.
